Global Synthetic Drugs Assessment 2020

The United Nations Office on Drugs and Crime (UNODC) presented the Global Synthetic Drugs Assessment 2020. It provides an analysis of the global synthetic drugs market. This report presents a global thematic analysis of the key trends and emerging developments of the synthetic drugs market as well as the recent trends in the manufacture of synthetic drugs.

The first part of this report provides options for responses to counter the synthetic drug problem. The second part presents a global thematic analysis of the key trends and emerging developments of the synthetic drugs market as well as the recent trends in the manufacture of synthetic drugs, including the effects of the COVID-19 pandemic. The third part provides the key findings of the synthetic drug situation in the different regions of the world.

 

The report is available follow this link>>>.

The Regional overviews highlight context-specific dynamics relating to the demand and supply of synthetic drugs in Africa, Americas, Asia, Europe and Oceania. The regional overview for Europe is available following this link>>>.

 

Use of new psychoactive substances in WB/SEE – challenges, needs and opportunities

Our member organisation NGO Re Generation, with support of Eurasian Harm Reduction Association, ERA – LGBTI Equal Rights Association for Western Balkans and Turkey and DPNSEE, invite you to participate in an online meeting “Use of new psychoactive substances in WB/SEE – challenges, needs and opportunities”.

This year, EHRA and the School of Law, Swansea University undertook the project “New Psychoactive Substance Use in Moldova, Belarus, Kazakhstan, Kyrgyzstan, Georgia, and Serbia” aiming to generate a more accurate picture of the use of new psychoactive substances (NPS) and to assess harm reduction and law enforcement responses to the emerging issues related to use of NPS. In addition, EHRA funded project #DAZNAMŠTARADIM implemented by NGO Re Generation. Both of the actions generated a more detailed picture on what are the specific issues related to NPS in Serbia. We believe that these issues should be communicated and discussed among CSOs in the Western Balkan/SEE region that work with and represent affected communities.

The meeting will be held via Zoom on Friday 06 November 2020 starting at 11:00 CET. The meeting will last approximately two hours. You can access it by following link: https://us02web.zoom.us/j/86130730814.

The invitation for the meeting with more details is available following this link>>>.

New Psychoactive Substance use in Eastern Europe

From the EHRA webpage

The phenomenon of new psychoactive substances (NPS) started decades ago with the growth and production of drugs that replicate the effects of controlled drugs (such as amphetamines, cocaine, cannabis and heroin) but avoid legislative control based on different chemical structures.

In recent years, the increasing use of NPS has led to new threats for health of people who use drugs (PWUD) – including overdose, psychotic reactions, high HIV risks due to multiple injections and increased number of sexual contacts. However, in many countries service providers such as harm reduction, drug treatment programs and ambulance services are not prepared to provide PWUD with quality support and counselling to reduce risks of NPS.

In the Central and Eastern Europe and Central Asia (CEECA) region the situation with NPS is truly alarming and has become one of the major challenges for the national public health systems, local NGOs, communities PWUD.

The Eurasian Harm Reduction Association (EHRA) in partnership with School of Law, Swansea University undertook the project “New Psychoactive Substance Use in Moldova, Belarus, Kazakhstan, Kyrgyzstan, Georgia, and Serbia” to generate a more accurate picture of the use of new psychoactive substances (NPS) and to assess harm reduction and law enforcement responses to the emerging issues related to use of NPS. Results from this project will supplement scarce international data on the use of NPS in these countries, present a more accurate picture of their use, and provide information to national civil society organizations (CSOs) for political advocacy.

Irena Molnar, a researcher from the non-governmental organization Re Generation (the only CSO that conducts activities aimed at dealing with NPS in Serbia, DPNSEE member organisation), prepared the report for Serbia, the only country involved in the project from South East Europe. Here is a brief overview of it:

The appearance of NPS in Serbia is not a new phenomenon, but their market share is very small. NPS have been talked about for a whole decade, although scientific research and answers to their appearance in the form of special services aimed at ensuring the health and well-being of users, but also the whole society, have not progressed at all.

Among other things, the report examines in detail the actions taken by the state in the context of this issue and formulates recommendations for improvement. For example, in order to improve the response to problems related to the emergence and use of NPS, greater state involvement is needed in terms of adapting to rapid market changes. This means not only putting substances on the banned list, for which Serbia is very up to date, but also improving the entire system.

To read the reports, follow this link>>>.